{"resolution": {"@star-print": "no-star-print", "form": {"current-chamber": {"#tail": " \n", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": " \n", "congress": {"#tail": "\n", "@display": "yes", "#text": "113th CONGRESS"}, "#tail": "\n", "legis-num": {"#tail": " \n", "#text": "H. RES. 91"}, "official-title": {"#tail": " \n", "@display": "yes", "#text": "Expressing support for designation of February 28, 2013, as Rare Disease Day."}, "session": {"#tail": "\n", "@display": "yes", "#text": "1st Session"}, "distribution-code": {"#tail": " \n", "@display": "yes", "#text": "IV"}, "action": {"action-date": {"#tail": " \n", "@date": "20130228", "#text": "February 28, 2013"}, "#tail": " \n", "@display": "yes", "action-desc": {"#tail": "\n", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for himself, ", "#text": "Mr. Carson of Indiana", "@name-id": "C001072"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Burgess", "@name-id": "B001248"}, {"#tail": ", ", "#text": "Mr. Cartwright", "@name-id": "C001090"}, {"#tail": ", ", "#text": "Mr. Cassidy", "@name-id": "C001075"}, {"#tail": ", ", "#text": "Mrs. Christensen", "@name-id": "C000380"}, {"#tail": ", ", "#text": "Mr. Conyers", "@name-id": "C000714"}, {"#tail": ", ", "#text": "Mr. Crowley", "@name-id": "C001038"}, {"#tail": ", ", "#text": "Mr. Holt", "@name-id": "H001032"}, {"#tail": ", ", "#text": "Mr. Lance", "@name-id": "L000567"}, {"#tail": ", ", "#text": "Ms. Lee of California", "@name-id": "L000551"}, {"#tail": ", ", "#text": "Mr. Levin", "@name-id": "L000263"}, {"#tail": ", ", "#text": "Ms. Norton", "@name-id": "N000147"}, {"#tail": ", and ", "#text": "Ms. Speier", "@name-id": "S001175"}, {"#tail": ") submitted the following resolution; which was referred to the ", "#text": "Ms. Wasserman Schultz", "@name-id": "W000797"}]}, "#text": " \n"}, "legis-type": {"#tail": " \n", "#text": "RESOLUTION"}}, "@resolution-stage": "Introduced-in-House", "@resolution-type": "house-resolution", "resolution-body": {"#tail": " \n", "@style": "traditional", "section": {"@section-type": "undesignated-section", "#tail": " \n", "text": {"#tail": "\n", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "federal-body", "#text": "House of Representatives", "@entity-id": "0050"}, "#text": "That the "}, "paragraph": [{"#tail": "\n", "text": {"#tail": "\n      ", "#text": "supports the designation of Rare Disease Day;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H8E3549E33DA645DEAE1303C7D5947A72", "#text": "\n        "}, {"#tail": "\n", "text": {"#tail": "\n      ", "#text": "recognizes the importance of improving awareness and encouraging accurate and early diagnosis of rare diseases and disorders; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H629F6AB3719C41D9BEC8E84F8FE0DACA", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "supports a national and global commitment to improving access to, and developing new treatments, diagnostics, and cures for, rare diseases and disorders."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "HC088E52639FF4A699EF0CD84B71774CE", "#text": "\n        "}], "@display-inline": "yes-display-inline", "#text": "\n      ", "@id": "H1DEE5EC10BA24ECDAB6851315574126F"}, "#text": " \n", "@id": "H1612C87309BA40B9AF92FFB979DFF67F"}, "@key": "H", "@dms-id": "HB202E2F34E084DE5BEAF497032D75DD5", "@public-private": "public", "#text": " \n", "preamble": {"#tail": " \n", "whereas": [{"#tail": "\n", "text": {"#tail": "\n    ", "#text": "Whereas rare diseases and disorders are those which affect small patient populations, typically populations smaller than 200,000 people in the United States;"}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "#text": "Whereas nearly 7,000 rare diseases affect 30,000,000 people in the United States and their families;"}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "#text": "Whereas children with rare genetic diseases account for more than half of the population affected by rare diseases in the United States;"}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "#text": "Whereas many rare diseases are serious, life-threatening, and lack an effective treatment;"}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "#text": "Whereas rare diseases and conditions include epidermolysis bullosa, progeria, sickle cell anemia, Tay-Sachs, cystic fibrosis, many childhood cancers, and fibrodysplasia ossificans progressiva;"}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "#text": "Whereas people with rare diseases experience challenges that include difficulty in obtaining an accurate diagnosis, limited treatment options, and difficulty finding physicians or treatment centers with expertise in their disease;"}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "Orphan Drug Act", "@value": "Orphan Drug Act"}, "#text": "Whereas great strides have been made in research and treatment for rare diseases as a result of the "}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and therefore a time to reflect upon its successes to date and challenges to be addressed in the future;", "@entity-type": "act", "#text": "Orphan Drug Act", "@value": "Orphan Drug Act"}, "#text": "Whereas 2013 marks the 30th anniversary of the "}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " have established special offices to advocate for rare disease research and treatments;", "@entity-type": "federal-body", "#text": "National Institutes of Health", "@entity-id": "7529"}], "#text": "Whereas both the "}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and remains a critical public voice for people with rare diseases;", "@entity-type": "act", "#text": "Orphan Drug Act", "@value": "Orphan Drug Act"}, "#text": "Whereas the National Organization for Rare Disorders, an organization established in 1983 to provide services to, and advocate on behalf of, patients with rare diseases, was a primary force behind the enactment of the "}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "#text": "Whereas the National Organization for Rare Disorders sponsors Rare Disease Day in the United States to increase public awareness of rare diseases;"}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "#text": "Whereas Rare Disease Day has become a global event occurring annually on the last day of February and observed in more than 60 countries in 2012;"}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "#text": "Whereas Rare Disease Day was observed in the United States for the first time on February 28, 2009;"}, "#text": "\n      "}, {"#tail": "\n", "text": {"#tail": "\n    ", "#text": "Whereas February 28, 2013, would be an appropriate date to designate as Rare Disease Day; and"}, "#text": "\n      "}, {"#tail": "\n  ", "text": {"#tail": "\n    ", "#text": "Whereas Rare Disease Day is anticipated to be observed globally in years to come, providing hope and information for rare disease patients around the world: Now, therefore, be it"}, "#text": "\n      "}], "#text": "\n"}}}